Literature DB >> 7096143

Acute hypervolemia, cardiac performance, and aerobic power during exercise.

I L Kanstrup, B Ekblom.   

Abstract

The relative importance of blood volume (BV) for the maximum aerobic power (VO2 max) was evaluated in healthy subjects by sequential measurements without intervention under two conditions: 1) after hemodilution with a plasma expander, thus increasing BV but keeping red cell mass constant and lowering hemoglobin concentration [Hb], and 2) after whole blood withdrawal, which restored BV to control conditions but reduced red cell mass and [Hb] to equal conditions under 1. After BV expansion (avg 700 ml), we found an unchanged VO2 max compared with control data despite lowered [Hb]. Cardiac output (Q) was increased after BV expansion at rest and during all exercise levels (maximum 27.4 and 29.5 l . min-1, respectively). Peak stroke volume was increased from 144 to 173 ml. Arterial blood pressures were either unchanged or lowered. In contrast, after blood letting to a similar [Hb], we found a significantly reduced VO2 max. These findings indicate a significant influence of the size of the blood volume on cardiac performance. The increased Qmax is discussed in relation to preload, inotropic state, heart rate, and afterload. Plasma volume expansion causes increased preload which may explain this primary effect on the central circulation (Frank-Starling effect).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096143     DOI: 10.1152/jappl.1982.52.5.1186

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  20 in total

Review 1.  Evidence and possible mechanisms of altered maximum heart rate with endurance training and tapering.

Authors:  G S Zavorsky
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

Review 2.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  CrossTalk opposing view: Heat acclimatization does not improve exercise performance in a cool condition.

Authors:  Lars Nybo; Carsten Lundby
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

4.  The heart rate increase at the onset of high-work intensity exercise is accelerated by central blood volume loading.

Authors:  Tadayoshi Miyamoto; Yoshitake Oshima; Komei Ikuta; Hiroshi Kinoshita
Journal:  Eur J Appl Physiol       Date:  2005-10-26       Impact factor: 3.078

Review 5.  Hormonal and plasma volume alterations following endurance exercise. A brief review.

Authors:  N Fellmann
Journal:  Sports Med       Date:  1992-01       Impact factor: 11.136

6.  Short-term high-intensity interval and continuous moderate-intensity training improve maximal aerobic power and diastolic filling during exercise.

Authors:  Sam Esfandiari; Zion Sasson; Jack M Goodman
Journal:  Eur J Appl Physiol       Date:  2013-11-27       Impact factor: 3.078

7.  Hyperhydration prior to a simulated second day of the 3-day moderate intensity equestrian competition does not cause arterial hypoxemia in Thoroughbred horses.

Authors:  B S Tennent-Brown; T E Goetz; M Manohar; A S Hassan; D E Freeman; J S Bundy; M R Evans
Journal:  Eur J Appl Physiol       Date:  2006-05-10       Impact factor: 3.078

8.  Immediate Re-Hydration Post-Exercise is Not Coincident with Raised Mean Arterial Pressure Over A 30-Minute Observation Period.

Authors:  Bartholomew Kay; Brendan J O'Brien; Nicholas D Gill
Journal:  J Sports Sci Med       Date:  2005-12-01       Impact factor: 2.988

9.  Plasma volume expansion 24-hours post-exercise: effect of doubling the volume of replacement fluid.

Authors:  Bartholomew Kay; Brendan J O'Brien; Nicholas D Gill
Journal:  J Sports Sci Med       Date:  2005-06-01       Impact factor: 2.988

Review 10.  Optimal use of fluids of varying formulations to minimise exercise-induced disturbances in homeostasis.

Authors:  D R Lamb; G R Brodowicz
Journal:  Sports Med       Date:  1986 Jul-Aug       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.